Andrew L. Guggenhime
2017
In 2017, Andrew L. Guggenhime earned a total compensation of $2.5M as Chief Financial Officer at Dermira, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $190,150 |
|---|---|
| Option Awards | $1,532,497 |
| Salary | $380,290 |
| Stock Awards | $401,850 |
| Total | $2,504,787 |
Guggenhime received $1.5M in option awards, accounting for 61% of the total pay in 2017.
Guggenhime also received $190.2K in non-equity incentive plan, $380.3K in salary and $401.9K in stock awards.
Rankings
In 2017, Andrew L. Guggenhime's compensation ranked 4,416th out of 14,666 executives tracked by ExecPay. In other words, Guggenhime earned more than 69.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,416 out of 14,666 | 70th |
Division Manufacturing | 1,554 out of 5,768 | 73rd |
Major group Chemicals And Allied Products | 449 out of 2,074 | 78th |
Industry group Drugs | 344 out of 1,730 | 80th |
Industry Pharmaceutical Preparations | 272 out of 1,329 | 80th |
Source: SEC filing on April 24, 2019.
Guggenhime's colleagues
We found three more compensation records of executives who worked with Andrew L. Guggenhime at Dermira in 2017.